In keeping with this, studies have shown the requirement of Trp53 knockout/down to recapitulate a less aggressive phenotype of IDH1R132H glioma compared with IDH1-wildtype glioma [47,48,49]; however, the mechanism by which TP53 alteration contributes to gliomagenesis remains unclear. The gene discussed is TP53; the disease is central nervous system cancer.